Global Sterile Injectable Drugs Market Predicted to Earn an Estimated US$901.3 billion Value by the end of 2025

Published on : Feb 08, 2018

Albany, New York, February 8, 2018: A fresh report, focusing on the global market scenario of sterile injectable drugs have been broadcasted to the massive database of Market Research Hub (MRH), with the title of “Sterile Injectable Drugs Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”. This 222-page study presents a complete perspective on global sterile injectable drugs market’s evolution throughout the above-mentioned forecast period in terms of revenue (in US$ Mn). The readers will gain access to vital information regarding current trends and future propositions of the market across various geographies. Some of the prime regions highlighted in the study are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Overview and Growth Forecast

Sterile injectable drugs is an effective and safe alternative over other medications, as it provides a faster recovery from diseases. The drugs are employed in the treatment of diseases which are unresponsive to oral medication, such as cancer, cardiovascular diseases, musculoskeletal, diabetes and other diseases. Due to its beneficial abilities, the Food and Drug Administration (FDA) in the U.S. is observed to approve sterile injectable drugs at a rapid rate.

As per the research outcomes, the global sterile injectable drugs market is expected to grow at an impressive CAGR of 11.1% between 2017 and 2025 to secure a valuation of US$901.3 bn by the end of the year 2025. In 2017, the market gained a valuation of US$387.1 bn. By region, North America had secured a commanding position in the global market with a 43.0% share in 2016.

In the initial section, the market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the sterile injectable drugs market and could influence the market in the near future. It has been analyzed that rising focus on the research and development of anti-cancer drugs and increasing number of chronic and cardiovascular diseases are anticipated to set the tone for a valuable growth in the near future.

Moving further, the report has segmented the global market for sterile injectable drugs based on major types, applications, usage, end users. By type, the large molecule market had earned a massive share of 54.6% in 2016. On the basis of class of drug, there could be segments such as peptide antibiotics, blood factors, immunoglobulins, vaccine, peptide hormones, insulin, cytokines, and monoclonal antibodies (mAbs) offering growth in the global market.

Competitive Tracking

Later, the authors of the report have decoratively profiled the key players in order to provide a sound understanding of how the competitive landscape could shape in the near future. This section presents details of companies operating in the sterile injectable drugs market which are Gilead, Baxter International Inc., Johnson & Johnson Services, Inc., Sanofi, Pfizer Inc., Merck & Co., Inc., and GlaxoSmithKline Plc. AstraZeneca, Sciences, Inc., Novartis AG, and Novo Nordisk A/S.

Request a Sample with TOC in a PDF format :

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top